Rapid Micro Biosystems, Inc.
NASDAQ:RPID
0.869 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.618 | 5.611 | 6.337 | 6.145 | 5.002 | 5.035 | 4.374 | 4.739 | 3.86 | 4.16 | 5.208 | 6.899 | 6.13 | 4.995 | 5.238 | 5.247 | 2.593 | 2.999 |
| Cost of Revenue
| 6.807 | 7.134 | 6.509 | 7.776 | 6.894 | 6.825 | 6.975 | 7.533 | 5.081 | 6.084 | 7.794 | 8.21 | 7.908 | 7.061 | 8.394 | 6.612 | 4.182 | 4.96 |
| Gross Profit
| -0.189 | -1.523 | -0.172 | -1.631 | -1.892 | -1.79 | -2.601 | -2.794 | -1.221 | -1.924 | -2.586 | -1.311 | -1.778 | -2.066 | -3.156 | -1.365 | -1.589 | -1.961 |
| Gross Profit Ratio
| -0.029 | -0.271 | -0.027 | -0.265 | -0.378 | -0.356 | -0.595 | -0.59 | -0.316 | -0.463 | -0.497 | -0.19 | -0.29 | -0.414 | -0.603 | -0.26 | -0.613 | -0.654 |
| Reseach & Development Expenses
| 3.744 | 3.842 | 3.318 | 3.116 | 3.233 | 3.153 | 3.403 | 2.973 | 2.965 | 3.525 | 2.855 | 2.441 | 2.337 | 2.147 | 1.625 | 2.224 | 1.244 | 1.438 |
| General & Administrative Expenses
| 5.818 | 5.627 | 5.537 | 6.204 | 6.728 | 6.467 | 7.132 | 7.189 | 6.404 | 6.094 | 5.76 | 5.308 | 3.625 | 3.203 | 3.121 | 2.541 | 1.943 | 2.371 |
| Selling & Marketing Expenses
| 3.627 | 3.281 | 3.161 | 3.498 | 3.201 | 3.462 | 4.124 | 3.93 | 3.484 | 3.456 | 3.355 | 3.063 | 3.122 | 2.275 | 1.813 | 1.447 | 1.236 | 1.466 |
| SG&A
| 9.445 | 8.908 | 8.698 | 9.702 | 9.929 | 9.929 | 11.256 | 11.119 | 9.888 | 9.55 | 9.115 | 8.371 | 6.747 | 5.478 | 4.934 | 3.988 | 3.179 | 3.837 |
| Other Expenses
| -0.023 | -0.029 | -0.017 | -0.026 | -0.029 | -0.011 | -0.011 | -0.021 | 0.381 | 0.103 | 0.004 | -0.809 | 0.008 | -0.011 | -0.002 | 0.018 | -0.001 | 0.007 |
| Operating Expenses
| 13.189 | 12.75 | 12.016 | 12.818 | 13.162 | 13.082 | 14.659 | 14.092 | 12.853 | 13.075 | 11.97 | 10.812 | 9.084 | 7.625 | 6.559 | 6.212 | 4.423 | 5.275 |
| Operating Income
| -13.378 | -14.273 | -12.188 | -14.449 | -15.054 | -14.872 | -17.26 | -16.886 | -14.074 | -14.999 | -14.556 | -12.123 | -10.862 | -9.691 | -9.715 | -7.577 | -6.012 | -7.236 |
| Operating Income Ratio
| -2.021 | -2.544 | -1.923 | -2.351 | -3.01 | -2.954 | -3.946 | -3.563 | -3.646 | -3.606 | -2.795 | -1.757 | -1.772 | -1.94 | -1.855 | -1.444 | -2.319 | -2.413 |
| Total Other Income Expenses Net
| 0.815 | 0.954 | 1.024 | -0.026 | -0.029 | 0.992 | 0.82 | 0.554 | 0.371 | 0.092 | 0.004 | -12.069 | -0.027 | -11.459 | -0.62 | 0.018 | -2.367 | 0.012 |
| Income Before Tax
| -12.563 | -13.319 | -11.164 | -13.382 | -14.01 | -13.88 | -16.44 | -16.332 | -13.703 | -14.907 | -14.571 | -24.967 | -11.813 | -22.082 | -11.319 | -8.445 | -9.193 | -7.987 |
| Income Before Tax Ratio
| -1.898 | -2.374 | -1.762 | -2.178 | -2.801 | -2.757 | -3.759 | -3.446 | -3.55 | -3.583 | -2.798 | -3.619 | -1.927 | -4.421 | -2.161 | -1.609 | -3.545 | -2.663 |
| Income Tax Expense
| 0.015 | 0.003 | 0.008 | 0.01 | 0.006 | 0.007 | 0.007 | 0.007 | -0.613 | 0.023 | 0.034 | 0.02 | 0.018 | 0.019 | 0.02 | 0.02 | 0.074 | 0.02 |
| Net Income
| -12.578 | -13.322 | -11.172 | -13.392 | -14.016 | -13.887 | -16.447 | -16.339 | -13.09 | -14.93 | -14.605 | -24.987 | -11.831 | -22.101 | -11.339 | -8.465 | -9.267 | -8.007 |
| Net Income Ratio
| -1.901 | -2.374 | -1.763 | -2.179 | -2.802 | -2.758 | -3.76 | -3.448 | -3.391 | -3.589 | -2.804 | -3.622 | -1.93 | -4.425 | -2.165 | -1.613 | -3.574 | -2.67 |
| EPS
| -0.29 | -0.31 | -0.26 | -0.31 | -0.33 | -0.32 | -0.39 | -0.38 | -0.31 | -0.35 | -0.35 | -0.71 | -0.31 | -0.7 | -0.36 | -0.27 | -0.29 | -0.25 |
| EPS Diluted
| -0.29 | -0.31 | -0.26 | -0.31 | -0.33 | -0.32 | -0.39 | -0.38 | -0.31 | -0.35 | -0.35 | -0.71 | -0.31 | -0.7 | -0.36 | -0.27 | -0.29 | -0.25 |
| EBITDA
| -12.55 | -13.162 | -11.394 | -13.668 | -14.283 | -14.872 | -17.26 | -16.152 | -13.693 | -14.336 | -14.552 | -12.549 | -10.854 | -9.358 | -9.398 | -7.226 | -5.63 | -6.755 |
| EBITDA Ratio
| -1.896 | -2.346 | -1.798 | -2.224 | -2.855 | -2.954 | -3.946 | -3.408 | -3.547 | -3.446 | -2.794 | -1.819 | -1.771 | -1.873 | -1.794 | -1.377 | -2.171 | -2.252 |